COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments
Short title: COVID-19 and severe asthma in real-life
Enrico Heffler 1,2; Aikaterini Detoraki3; Marco Contoli 4; Alberto Papi4; Giovanni Paoletti 1,2; Giacomo Malipiero 1; Luisa Brussino 5; Claudia Crimi 6; Daniela Morrone 7; Marianna Padovani 4; Giuseppe Guida8; Alberto Giovanni Gerli 9; Stefano Centanni 10; Gianenrico Senna 11; Pierluigi Paggiaro 12; Francesco Blasi13,14; Giorgio Walter Canonica 1,2on behalf of SANI Working Group *
1 Personalized Medicine, Asthma and Allergy - Humanitas Clinical and Research Center IRCCS - Rozzano (MI), Italy
2 Department of Biomedical Sciences – Humanitas University – Pieve Emanuele (MI), Italy
3 Department of Internal Medicine, Clinical Immunology, Clinical Pathology and Infectious Disease, Azienda Ospedaliera Universitaria Federico II, Napoli, Italy.
4 Department of Morphology, Surgery and Experimental Medicine - University of Ferrara – Ferrara, Italy.
5 Department of Medical Sciences, AO Ordine Mauriziano Umberto I – University of Torino - Torino, Italy.
6 Department of Clinical and Experimental Medicine - University of Catania - Catania, Italy.
7 Severe Asthma Network in Italy (SANI) infrastructure – Milano, Italy
8 Allergy and Pneumology Unit - A.O. S. Croce e Carle – Cuneo, Italy.
9 Management Engineering Tourbillon Tech srl - Padova, Italy.
10 Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences – University of Milano - Milano, Italy.
11 Asthma Center and Allergy Unit - Verona University Hospital - Verona, Italy.
12 Department of Surgery, Medicine, Molecular Biology and Critical Care - University of Pisa - Pisa, Italy.
13 Internal Medicine Department – Respiratory Unit and Adult Cystic Fibrosis Center – Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico - Milano, Italy.
14 Department of Pathophysiology and Transplantation – University of Milano – Milano, Italy
* SANI Working Group: Bonavia M., Bucca C., Caiaffa MF., Calabrese C., Camiciottoli G., Caruso C., Conte ME., Corsico AG., Cosmi L., Costantino MT., Crimi N., D’Alò S., D’Amato M., Del Giacco S., Farsi A., Favero E., Foschino BMP., Guarnieri G., Lo Cicero S., Lombardi C., Macchia L., Mazza F., Menzella F., Milanese M., Montuschi P., Montagni M., Nucera E., Parente R., Passalacqua G., Patella V., Pelaia G., Pini L., Puggioni F., Ricciardi L., Ricciardolo FLM., Richeldi L., Ridolo E., Rolla G., Santus P., Scichilone N., Solidoro P., Spadaro G., Vianello A., Viviano V., Yacoub MR., Zappa MC.
Corresponding Author:
Prof. Enrico Heffler
Personalized Medicine, Asthma and Allergy
Istituto Clinico Humanitas
Via Alessandro Manzoni 56
20089 – Rozzano (MI) – Italy
Tel: +39 0282247013
Fax: + 39 0282246484
Email:enrico.heffler@hunimed.eu
Conflict of interest statements:
Funding statement: SANI is supported through unrestricted grants by AstraZeneca, Glaxo Smith Kline, Novartis & Sanofi Genzyme
Aknowledgements :
We are grateful to Silvia Rabotti, Concetta Sirena & the SANI staff for the invaluable work in managing the network.